Serotonergic mechanisms involved in the attentional and vigilance task performance of rats and the palliative action of aniracetam

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 361, Issue 5, 2000, Pages 521-528

  Nakamura, Kazuo ^a   Kurasawa, Mitsue ^a  

^a NIPPON ROCHE RESEARCH CENTER   (Japan)

Author keywords

5 HT(1A) and 5 HT(2A) receptors; Aniracetam; Attention and vigilance; Choice reaction task; Metabolites

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 4 IODO 2,5 DIMETHOXYAMPHETAMINE; ALPRENOLOL; ANIRACETAM; RITANSERIN; SEROTONIN 1A RECEPTOR; SEROTONIN 2A RECEPTOR; SEROTONIN 2C RECEPTOR; SEROTONIN RECEPTOR;

ALERTNESS; ANIMAL EXPERIMENT; APPETITE; ARTICLE; ATTENTION; BODY TEMPERATURE; COGNITION; CONTROLLED STUDY; DRUG EFFECT; LOCOMOTION; MALE; MOOD; NONHUMAN; RAT; RECEPTOR INTRINSIC ACTIVITY; REGULATORY MECHANISM; RESPONSE TIME; SEROTONINERGIC SYSTEM; SLEEP; TASK PERFORMANCE; WAKEFULNESS;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; AMPHETAMINES; ANIMALS; ATTENTION; MALE; NOOTROPIC AGENTS; PALLIATIVE CARE; PSYCHOMOTOR PERFORMANCE; PYRROLIDINONES; RATS; RATS, WISTAR; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT1; SEROTONIN AGONISTS;

EID: 0034021441     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002100000222     Document Type: Article

References (44)

1. Ashby CR Jr, Edwards E, Harkins K, Wang RY (1989) Effects of (±)-DOI on medial prefrontal cortex cells: a microiontophoretic study. Brain Res 498:393-396
2. 1A ligands given systemically and locally in different brain regions. Rev Neurosci 9:265-273
3. 1A receptors on neurons of the rat midbrain tectum. Brain Res 556:259-266
4. Carli M, Samanin R (1992) Serotonin2 receptor agonists and serotonergic anorectic drugs affect rats' performance differently in a five-choice serial reaction time task. Psychopharmacology 106:228-234
5. Cassaday HJ, Hodges H, Gray JA (1993) The effects of ritanserin, RU 24969 and 8-OH-DPAT on latent inhibition in the rat. J Psychopharmacol 7:63-71
6. 1A receptors and carbachol-stimulated phosphoinositide turnover in the rat hippocampus. J Neurochem 56:1276-1285
7. Evenden J, Ryan C, Palejko W (1995) The effects of repeated treatment with 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) on the lever press responding of the rat under FI and DRL schedules of food reinforcement. Psychopharmacology 120:81-92
8. 2 receptors. Br J Pharmacol 84:743-753
9. Harrison AA, Everitt BJ, Robbins TW (1997a) Central 5-HT depletion enhances impulsive responding without affecting the accuracy of attentional performance: interactions with dopaminergic mechanisms. Psychopharmacology 133:329-342
10. Harrison AA, Everitt BJ, Robbins TW (1997b) Doubly dissociable effects of median-and dorsal-raphé lesions on the performance of the five-choice serial reaction time test of attention in rats. Behav Brain Res 89:135-149
11. Himori N, Imai M, Nakamura Y (1992) Potentiating action of the cerebral insufficiency enhancer, aniracetam, on adenosine triphosphate production in rat brain mitochondria. Pharmacol Commun 2:211-216
12. 2 agonist DOI: effects of MDL 100,907, clozapine, risperidone and haloperidol. Behav Brain Res 88:43-49
13. Hoyer D, Clarke JR, Fozard JR, Hartig PR, Martin GR, Mylecharane EJ, Saxena PR, Humphrey PPA (1994) VII. International union of pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol Rev 46:157-203
14. Jäkälä P, Sirvio J, Jolkkonen J, Riekkinen P Jr, Acsady L, Riekkinen P (1992) The effects of p-chlorophenylalanine-induced serotonin synthesis inhibition and muscarinic blockade on the performance of rats in a 5-choice serial reaction time task. Behav Brain Res 51:29-40
15. Katsunuma H, Shimizu T, Ogawa K, Kubo H, Ishida H, Yoshihama A (1998) Treatment of insomnia by concomitant therapy with zopiclone and aniracetam in patients with cerebral infarction, cerebroatrophy, Alzheimer's disease and Parkinson's disease. Psychiatry Clin Neurosci 52:198-200
16. Kawajiri S, Taniguchi K, Sakurai T, Yamasaki T (1994) Nefiracetam enhances acetylcholine outflow from the frontal cortex: in vivo microdialysis study in the rat. J Neural Transm 98:15-22
17. Kumar V (1999) Post-stroke depression and treatment strategies including Aniracetam. Int J Geriat Psychopharmacol 2:40-46
18. Leonard BE (1996) Serotonin receptors and their function in sleep, anxiety disorders and depression. Psychother Psychosom 65: 66-75
19. Lipowski ZJ (1990) In: Lipowski ZJ (eds) Delirium: Acute Confusional States. Oxford University Press, New York
20. Lubow RE (1997) Latent inhibition as a measure of learned inattention: some problems and solutions. Behav Brain Res 88: 75-83
21. Luthman J, Lindqvist E, Dell'anna E, Kojima H, Shiotani T, Tachizawa H, Olson L (1991) Effects of DM-9384, a pyrrolidone derivative, on ischemia-induced changes in the central monoamine systems. Pharmacol Biochem Behav 41:231-234
22. Martin JR, Haefely WE (1993) Pharmacology of aniracetam, a novel pyrrolidinone derivative with cognition enhancing activity. Drug Invest 5:4-49
23. 2 presynaptic receptors mediate inhibition of glutamate release from cerebellar mossy fiber terminals. Eur J Pharmacol 202:185-190
24. Murai S, Saito H, Itoh T (1991) Acute and long-term effects of aniracetam on the levels of monoaminergic, cholinergic, and amino acidergic substrates in discrete brain regions of mice. Clin Rep 25:285-301
25. Nakamura K, Shirane M (1999) Activation of the reticulothalamic cholinergic pathway by the major metabolites of aniracetam. Eur J Pharmacol 380:81-89
26. Nakamura K, Kurasawa M, Tanaka Y (1998a) Scopolamine model of delirium in rats and reversal of the performance impairment by aniracetam. Drug Dev Res 43 (2):85-97
27. Nakamura K, Kurasawa M, Tanaka Y (1998b) Apomorphine-induced hypoattention in rats and reversal of the choice performance impairment by aniracetam. Eur J Pharmacol 342:127-138
28. Otomo E, Hirai S, Terashi A, Hasegawa K, Tazaki Y, Araki G, Itoh E, Nishimura T, Furukawa T (1991) Clinical usefulness of aniracetam for psychiatric symptoms in patients with cerebrovascular disorders: Double-blind trial against placebo. J Clin Exp Med 156:143-187
29. Petkov VD, Grahovska T, Petkov VV, Konstantinova E, Stancheva S (1984) Changes in the brain biogenic monoamines of rats, induced by piracetam and aniracetam. Acta Physiol Pharmacol Bulg 10:6-15
30. Pizzi M, Fallacara C, Arrighi V, Memo M, Spano P (1993) Attenuation of excitatory amino acid toxicity by metabotropic glutamate receptor agonists and aniracetam in primary cultures of cerebellar granule cells. J Neurochem 61:683-689
31. Puumala T, Sirviö J (1998) Changes in activities of dopamine and serotonin systems in the frontal cortex underlie poor choice accuracy and impulsivity of rats in an attention task. Neuroscience 83:489-499
32. Rada PV, Mark GP, Hoebel BG (1993) In vivo modulation of acetylcholine in the nucleus accumbens of freely moving rats: I. inhibition by serotonin. Brain Res 619:98-104
33. 1A and muscarinic acetylcholine receptors jointly regulate passive avoidance behavior. Eur J Pharmacol 262:77-90
34. Robbins TW (1997) Arousal system and attentional processes. Biol Psychol 45:57-71
35. Sarter M (1994) Neuronal mechanisms of attentional dysfunction in senile dementia and schizophrenia: two sides of the same coin? Psychopharmacology 114:539-550
36. Senin U, Parnetti L, Cucinotta D, Criscuolo D, Longo A, Marini G (1993) Clinical experience with aniracetam in the treatment of senile dementia of the Alzheimer's type and related disorders. Drug Invest 5 (Suppl. 1):96-105
37. Shimizu H, Tatsuno T, Tanaka H, Hirose A, Araki Y, Nakamura M (1992) Serotonergic mechanism in anxiolytic effect of tandospirone in the Vogel conflict test. Jpn J Pharmacol 59:105-112
38. Solomon PR, Kiney CA, Scott DR (1978) Disruption of latent inhibition following systemic administration of para-chlorophenylalanine (PCPA). Physiol Behav 20:265-271
39. Solomon PR, Nichols GL, Kiernan JM, Kamor RS Kaplan LJ (1980) Differential effects of lesions in medial and dorsal raphé of the rat: latent inhibition and septohippocampal serotonin levels. J Comp Physiol Psychol 94:145-154
40. Sprouse JS, Aghajanian GK (1988) Responses of hippocampal pyramidal cells to putative serotonin 5-HT1a and 5-HT1b agonists: a comparative study with dorsal raphé neurons. Neuropharmacology 27:707-715
41. 2 receptor-mediated head-twitch response in rodents as a hallucination model. Drug Dev Res 44:131-139
42. 1 receptors and of catecholaminergic systems in the behavioural response to 8-hydroxy 2-(di-n-propylamino)tetralin in the rat. Eur J Pharmacol 106:271-282
43. 1A agonists measured with the force swim test. Psychopharmacology 101:497-504
44. 2 agonist, DOI, on 5-HT neuronal firing in the dorsal raphé nucleus and 5-HT release and metabolism in the frontal cortex. Br J Pharmacol 99:221-222